Marsh & McLennan Companies (MMC)
(Real Time Quote from BATS)
$218.69 USD
+1.94 (0.90%)
Updated Jul 22, 2024 11:14 AM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Marsh & McLennan (MMC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$214.50 | $238.00 | $185.00 | -1.04% |
Price Target
Based on short-term price targets offered by 18 analysts, the average price target for Marsh & McLennan comes to $214.50. The forecasts range from a low of $185.00 to a high of $238.00. The average price target represents a decline of 1.04% from the last closing price of $216.75.
Analyst Price Targets (18)
Broker Rating
Marsh & McLennan currently has an average brokerage recommendation (ABR) of 2.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms. The current ABR compares to an ABR of 2.79 a month ago based on 19 recommendations.
Of the 20 recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 15% and 5% of all recommendations. A month ago, Strong Buy made up 15.79%, while Buy represented 5.26%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MMC.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 14 | 13 | 13 | 13 | 13 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.80 | 2.79 | 2.79 | 2.79 | 2.79 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/19/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
7/19/2024 | Roth Capital Partners | Harry Fong | Hold | Hold |
7/12/2024 | Goldman Sachs | Robert A Cox | Strong Sell | Strong Sell |
7/9/2024 | Dowling & Partners | Joe Oscar Christiana | Not Available | Hold |
4/22/2024 | UBS | Brian R Meredith | Not Available | Strong Buy |
4/19/2024 | Atlantic Equities | John Heagerty | Hold | Hold |
4/19/2024 | Not Identified | Not Identified | Hold | Hold |
4/18/2024 | William Blair | Adam Klauber | Hold | Hold |
4/11/2024 | Evercore Partners | David Motemaden | Strong Buy | Strong Buy |
4/11/2024 | Wells Fargo Securities | Elyse Greenspan | Strong Buy | Hold |
4/10/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Sell | Moderate Sell |
4/1/2024 | Cowen & Co. | Andrew S Kligerman | Hold | Hold |
3/15/2024 | BMO Capital Markets | Michael Zaremski | Hold | Hold |
1/25/2024 | Not Identified | Not Identified | Hold | Hold |
10/20/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.80 |
ABR (Last week) | 2.79 |
# of Recs in ABR | 20 |
Average Target Price | $214.50 |
LT Growth Rate | 8.10% |
Industry | Insurance - Brokerage |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | 1.61 |